The researcher wants to examine the efficacy of mushroom extract supplementation on fetal loss. Yes, this research is permitted.
<h3>How to illustrate the information?</h3>
The organization in charge of examining potential research studies to determine their ethicality is known as the Institution Review Board.
The rules are set in subpart B for fetuses and expectant mothers, and the most crucial issues are as follows:
If the potential hazards have been investigated and are well understood, research studies are ethical.
If a research study benefits the fetus or the mother, it is ethical.
When there is little to no risk and no benefit to either the mother or the fetus, research studies are ethical.
Therefore, the research is permitted
Learn more about research on:
brainly.com/question/25015657
#SPJ1
A researcher wants to examine the efficacy of mushroom extract supplementation on fetal loss, low birth weight, and severe preterm birth in healthy pregnant women. she plans to enroll women who are 12-26 weeks pregnant and randomize them to either receive the intervention or placebo until delivery. the irb determines this intervention presents greater than minimal risk to the pregnant women subjects, and potential direct benefit to both mother and fetus. is this research permitted under subpart b?
